Unsupervised Decolonization
PreclinicalSmall molecule
Unsupervised Decolonization is one of 9 small molecule programs targeting Staphylococcus Aureus. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
9 competitors in Staphylococcus Aureus
#DrugCompanyPhaseTrials
1Acanya
PfizerApproved
Vancocin
HHikma Pharmaceuticals LLC
Approved
Ancef
BBaxter Healthcare Corporation
Approved
Trimethoprim-Sulfamethoxazole
AstellasPhase 3
Duracillin a-S
SanofiPhase 3
Chirocaine
PPurdue Pharma LP
Preclinical
AZD7760
AstraZenecaPreclinical
Unsupervised Decolonization
UUniversity of Pennsylvania
Preclinical
Neosporin
NNorthwestern University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Unsupervised Decolonization. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Pennsylvania